<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-viruses-11-00928">
 <label>31.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rudenko</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Yeolekar</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Kiseleva</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Isakova-Sivak</surname>
    <given-names>I.</given-names>
   </name>
  </person-group>
  <article-title>Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories</article-title>
  <source>Vaccine</source>
  <year>2016</year>
  <volume>34</volume>
  <fpage>5436</fpage>
  <lpage>5441</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2016.08.018</pub-id>
  <pub-id pub-id-type="pmid">27593158</pub-id>
 </element-citation>
</ref>
